---
ticker: "CRM"
company: "Salesforce, Inc."
date: "2026-10-26"
view: "Buy"
fair_value: 291.43
price: 247.55
price_source: "last regular-session trade 15:59:59 ET 2026-10-26 ($247.545; official close 2026-10-23 $248.57)"
price_time: "2026-10-26T19:59:59Z"
price_vs_fair_value: "-15.1%"
bear: 106.95
bull: 572.3
exit_price: 381.13
p_price_justified: "over 50%"
restated: "2026-10-26"
method: "case-spread-2026-10-24"
original_fair_value: 291
original_view: "Buy"
page: "https://alpha.dming.si/research/2026-10-26-crm"
---

# CRM · Salesforce, Inc. · Buy

Research report as of 2026-10-26, partly unblinded. Page: https://alpha.dming.si/research/2026-10-26-crm

We value CRM at $291 a share. The report's $247.55 price (Oct 26, 2026) was 15% below fair value: Buy.

_Restated Oct 26, 2026 (method case-spread-2026-10-24); the report's original value was $291, Buy._

| Lens | Range | Marks |
| --- | --- | --- |
| Our report | $107 to $572 | fair $291; original $291 |
| Our simulation | $132 to $560 | median $268 |
| Street targets (10) | $215 to $325 | average $274, median $275 |
| Price | | $247.55 |

Bands run from our bear to bull (the hollow mark is the original $291), our simulation's 10th to 90th percentile and the Street's low to high. Street targets forecast future prices, not value today. Market data, captured Oct 26, 2026.

| Figure | Value |
| --- | --- |
| Fair value | $291 |
| Price | $247.55 (market data, Oct 26, 12:59 PM PT) |
| Five-year return | 14.2% (a year, at the report's price) |
| Bear / bull | $107 / $572 |
| Exit price | $381 (on Jan 31, 2032) |
| Confidence | 28% |
| Price against our scenarios | The price is justified in over 50% of our scenarios (4,000 simulated outcomes, each drawing the uncertain drivers from ranges we chose: our judgement, not a measured chance) |

**What the price needs.** Any one of these, on its own, would justify the price:

- Data and platform net retention: needs 95.6%, we have 106.0%
- Core non-GAAP margin FY32: needs 33.6%, we have 37.5%

_This text argues the original call. The current figures are at the top._

As of 2026-10-26 · partly unblinded

**Original call, Oct 26, 2026 (before the Oct 26, 2026 restatement)**

- **Fair value today:** $291 per diluted share (cost of equity 10.14%)
- **Price:** $247.55, last regular-session trade 2026-10-26 15:59:59 ET (official close 2026-10-23 $248.57) → 18% upside to fair value
- **Five-year exit price:** $381 on 2032-01-31, after $40.1B of debt and leases (mean of the long fade $201 and the outside view $561 at 30.9x EV/EBIT; at 10/20 fade years $370/$391; the value-driver formula is not meaningful because the mature return equals the cost of capital)
- **Five-year return:** 14.2% a year from $247.55 to the central exit, payouts included, above the 10.14% cost of equity
- **Bear / bull today:** $107 / $572 from coherent operating cases
- **Confidence:** 28.5%: the share of our 4,000 simulated fair values within ±20% of the central $291 ($233-349; confidence.txt); subjective, not calibrated
- **Moat:** The customer record and the workflows, permissions and data built on it over two decades; it holds the record, not the interface
- **Market expects:** Our central forecast valued at about 23.5x FY32 operating profit at the exit instead of 30.9x; the Street's revenue is within 1% of ours to FY29
- **Price needs:** Either alone, everything else central: data-group net retention 95.6% (ours 106%), or a FY32 core non-GAAP margin of 33.6% (ours 37.5%); no seat, price or AI agent revenue driver reaches the price alone within its range (odds.json)
- **Odds:** P(price justified): 56%, in the over-50% band (subjective, not calibrated); simulated median $268, 10th to 90th $132-560
- **Key driver:** Core non-GAAP margin in FY32: about $12 a share a point (33% gives $241, 41% gives $331; held at the FY27 guide's 34.3%, $255)
- **Street:** Average 12-month target $274.18 (median $275, range $215-325); the one target set in the last month is $250, ten over the quarter average $258.30, 23 over the year $272.13: falling (market data via research-check, 2026-10-26). An expectations reference, not validation

**The answer.** Salesforce is worth about $291 a share if AI agents shrink its
customer-service seats slowly, prices per seat keep rising as customers move
to premium editions, and its data and integration products keep growing
about 8% a year. Frontier AI labs are a real threat, but to the interface and
to seat-priced work, not yet to the customer record: in the world where the
threat lands in full, which is our bear case, the stock is worth about $107,
and most of that loss comes not from fewer seats but from agents reaching the
data without paying Salesforce for the platform, and from the margin that
goes with it.

Terms used throughout. The *central* case is our most likely path; the
*bear* is the coherent world in which the AI threat lands; the *bull* is the
world in which agents run through Salesforce. *Seats* are paid user licences.
*AI agent revenue* is what Salesforce reports as Agentforce ARR (its agents,
Slackbot, Headless 360), sold per user, per action or per resolution; we add
Fin, the customer-service agent it bought in September. *Headless* means
software reached by an agent through programming interfaces (APIs and MCP, an
open standard for connecting AI agents to software) rather than by a person
at a screen. Salesforce's fiscal year ends January 31: FY32 ends 2032-01-31.

## 1. Is Anthropic, and frontier AI generally, a threat to Salesforce?

Yes, and the forecast carries it as six drivers with ranges rather than a
discount on the answer. What the evidence says, question by question:

**Seats against agents doing the work.** Salesforce is paid mostly per
person: Sales Cloud ($9.0B in FY26) and Service Cloud ($9.8B) are seat
products. An agent that resolves a support case removes the reason for a
service seat. This is already visible inside Salesforce: its CEO said its
support headcount fell from about 9,000 to about 5,000 as agents took about
half of the cases (podcast, September 2025, as relayed by the press), and its
own help agent resolves 64% of conversations without a person (Q2 FY27
call). Gartner forecasts that agents will resolve 80% of common service
issues by 2029. Against that, Salesforce says Sales, Service and Slack seats
all grew year on year in Q2 FY27 and attrition is near its lowest (CEO and
CFO, 2026-08-26), and 87% of customers say a company must offer a human
(Gartner survey, 2026-08-04). Our central has Service seats rising 1% in FY28,
flat in FY29, then falling 2-3% a year (7% fewer by FY32); the bear has them
falling to 64% of today. Price per seat offsets most of the central loss:
list prices rose 9% (2023) and 6% (2025), and the September 2026 Core,
Advanced and Max editions list 11-13% above the editions they replace, with
Slack, agents and consumption credits bundled in.

**Does the lab, or its enterprise partner, displace the system of record, or
only the interface on top?** So far only the interface, and Salesforce chose
that itself. In Claudeforce (company release, 2026-08-26) Salesforce put its
CRM inside Claude: a seller works in Claude, which reads Salesforce, Slack and
other connectors; actions are routed back through Salesforce "to help ensure
business rules are always enforced". The CEO's line was "the UI is the AI."
Anthropic's S-1 (filed 2026-10-26) lists Salesforce among the data platforms
through which customers adopt Claude, says Salesforce has built products on
Claude that reach millions of users, and says Anthropic "may from time to
time compete with enterprise software and application companies in select
categories" (p. 237) and competes, and may increasingly compete, with its own
software-as-a-service customers (p. 56). Its products for knowledge work
(Claude Cowork, Claude for Financial Services) do work on top of records; the
filing describes no plan to hold a customer database. OpenAI's Frontier
platform (February 2026, press) competes for the same orchestration layer.
The record itself is hard to move: it carries twenty years of a customer's
data model, permissions, audit and integrations. What can move is who the
customer pays for the work done on it. That is the bear.

**Agentforce's real monetisation.** No reported revenue line isolates it.
Agentforce ARR, a management metric, passed $0.5B in Q3 FY26, $1.2B in Q1
FY27 and $1.5B in Q2 FY27, after Salesforce widened it to include Slackbot
and Headless 360, so its growth rate is not like for like. We put FY27
revenue in that scope at $1.3B. Central: $6.0B by FY32. Bear: $2.5B, because
the agent spend goes to the labs and their partners. Bull: $9.0B. We give it
a 25% operating margin in the central (15% bear, 35% bull) because agent
revenue carries model costs that seat revenue does not. The CFO said on
2026-08-26 that headless monetisation is still being worked through; MCP
and command-line calls into Salesforce rose sixfold in that quarter. Calls
are not revenue yet.

**Customer-service seat compression, in dollars.** One driver at a time, it
is smaller than the debate suggests: three more points a year of Service
seat decline costs $9 a share; two points less price growth $12; AI agent
revenue of $2.5B instead of $6B $10. Where the threat lands in full, the
walk from the central $291 to the bear $107 (`threat_bridge.txt`) is:

| Step (bear values added in turn) | Value | Change |
| --- | ---: | ---: |
| Central | $291 | |
| Service seats to 64% of today by FY32 | $272 | -$19 |
| Sales seats to 86% | $260 | -$13 |
| Price per seat flat after FY28 | $245 | -$15 |
| AI agent revenue $2.5B at a 15% margin | $229 | -$16 |
| Data and platform net retention 99% (agents reach data directly) | $190 | -$39 |
| Slack, Marketing and Commerce, services slower | $178 | -$12 |
| Core margin 33%, stock pay 9.5%, restructuring 1.6% | $136 | -$42 |
| Less acquisition spending, no growth after FY32 | $136 | -$0 |
| The bear's exit multiple (21.5x instead of 30.9x) | $107 | -$29 |

Seats and price together are $47 of the $184. The larger losses are the data
platform ($39), where MuleSoft, Tableau, Informatica and Data 360 are
exactly what an agent with direct data access does not need, and the margin
($42) of a seat business that shrinks while its cost base does not. So the
items to watch are data-group growth and the margin, not the headline seat
count.

## 2. The business: who pays for what

Customers rent Salesforce by the seat for one to three years, billed in
advance, so growth releases cash (unearned revenue less receivables and
contract costs was 11.8% of FY26 revenue; 10-K). FY26 revenue $41.5B. From
FY27 Salesforce reports two groups: Agentforce Apps (Sales, Service,
Marketing, Commerce, Slack; $14.1B in H1 FY27, +8% in constant currency in
Q2) and Data 360, Headless Platform and Other (Data 360, Informatica,
MuleSoft, Tableau and the platform; $7.3B, +20% in Q2 with Informatica,
about +6% without it in Q2 and +10% in Q1). Marketing and Commerce were flat
to down in FY26 (CFO: "early signs of recovery"). Slack had its fastest new
bookings growth since the acquisition in Q2 FY27.

Following the money. A $25B accelerated share buyback in March 2026 was paid
for with $25B of new notes; debt is $39.5B against $11.4B of cash and
securities at 2026-07-31 (10-Q). Since then Salesforce has paid about $5.1B
for Contentful and Fin and agreed to pay $5.66B in cash for Braze (8-K
2026-10-20; close in FY28). Cash acquisitions over FY17-FY26 were $37B, 15%
of the decade's revenue, and the after-tax return on the capital it added in
each five-year window, goodwill included, was 0.6% to 12.1% (median 5.8%;
`output.txt`): Salesforce has bought growth at or below its cost of capital.
Strategic investments carry $11.3B, $5.1B of it Anthropic, marked only on
observable transactions; a listing above that mark would add to value (each
$1B after tax is about $1.25 a share). Stock pay is $3.5B a year (9.0% of
revenue guided for FY27) and is charged as a cost.

## 3. Results against the bar

Salesforce guides close to its results: revenue beat the guide midpoint in
six of the last eight quarters, by a median 0.51% and never more than 1.17%
(`output.txt`). Q2 FY27 revenue was $11,345M against an $11.27-11.35B guide;
cRPO (contracted revenue for the next twelve months) $33.5B, +14% in
constant currency, a point above the guide, about 10% without Informatica.
The FY27 guide is $46.1-46.4B. Its long-range targets have run high: "$50
billion in revenue in FY26" (2022) became $41.5B. The FY30 target is $63B+
including Informatica and deals announced by May 2026 (Investor Day,
2026-09-16), before Braze.

## 4. Our forecast and value

Model: `model.py`, output in `output.txt`; the
exit multiple in `exit_choices.py`.

| Central | FY27 | FY28 | FY29 | FY30 | FY31 | FY32 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue $B | 46.4 | 51.0 | 55.2 | 59.1 | 63.1 | 67.7 |
| Growth | 11.7% | 10.0% | 8.3% | 7.0% | 6.8% | 7.3% |
| Sales + Service $B | 20.1 | 21.6 | 22.6 | 23.3 | 23.7 | 24.0 |
| AI agent revenue $B | 1.3 | 1.8 | 2.4 | 3.3 | 4.4 | 6.0 |
| Data group $B (before acquisitions) | 14.6 | 15.7 | 17.0 | 18.3 | 19.8 | 21.4 |
| GAAP operating margin | 20.4% | 19.5% | 20.6% | 21.9% | 22.8% | 23.3% |
| NOPAT $B | 7.5 | 7.9 | 9.0 | 10.2 | 11.4 | 12.5 |

FY28 organic growth is 7.7%, close to today's 7-8%; Braze and further
acquisitions (3.5% of revenue a year) add the rest. Sales plus Service grow
19% by FY32, nearly all of it price. Our FY30 $59.1B is 6% below
management's $63B+ even with Braze. The GAAP margin rises because the core
non-GAAP margin goes from 34.3% to 37.5% while amortization of acquired
intangibles falls; stock pay stays at 9.0% and restructuring at 1.2%. Braze
carries its own margin, not Salesforce's: 8.3% non-GAAP in FY28 (its FY27
guide, release 2026-09-08) rising to 20% by FY32 (our assumption), with
stock pay at its Q2 FY27 15.7% of revenue; that holds the total non-GAAP
margin to 36.0% in FY32.

**Value.** The five-year exit is the mean of two views. The *long fade*
carries FY32 profit fifteen more years, fading growth to 3% and the return on
new capital from the forecast's own 65% down to a mature 9.28%, the cost of
capital. The method's rule holds each case at the return on its own FY32
capital (16.3% in the central, with goodwill counted because the growth is
bought), never above the company's median five-year return and never below
the cost of capital. Salesforce's median, 5.8%, is below the cost of
capital, so the floor sets it. Growth after FY32 still adds value while the
return is above the cost of capital and adds none once it reaches it (FY33
growth of 0% instead of 7% would cost $21 a share). After debt, the fade
gives $201 a share. The *outside view* prices FY32 operating profit at
30.9x, which gives $561. The two differ by 179%, and the input that drives
it is the mature return: the fade says Salesforce's acquired growth will in
the end earn no more than its cost, the outside view prices the franchise
as peers were priced. We hold both, and the mean is $381. With five years
of owner cash, after interest, paid out and discounted at 10.14%, it is
worth $291 today.

**The exit multiple and the judgment range.** The method's default, anchor
(d), is the median of six peers' own ten-year medians, 34.4x (Adobe 41.2x,
Oracle 20.9x, SAP 23.7x, Intuit 41.6x, Autodesk 49.3x, Microsoft 27.6x);
Salesforce's own history has too few years with meaningful GAAP profit to
count. Those peers earned their multiples at a median 13.9% revenue growth;
our central grows about 7% at the exit. We do not take Salesforce's own
multiples from its faster years, and no shared growth adjustment predicts
better out of sample. What we use: software companies whose peers' multiple
was earned at 10% growth or more and which grew 5-10% five years later
fetched 0.891x (1996-2009) and 0.909x (2010-2021) of what all companies of
their own era fetched. 34.4x × 0.900 = 30.9x. The support is weak, weaker
than in our Veeva revision: the sample leaves out companies taken over or
failed, it requires each company's own ten-year history, which Salesforce
lacks, and its ratio is measured against anchors that include the
company's own leg, while Salesforce's anchor is the peers' alone. The range
shows what else is defensible:

| Exit multiple (EV / FY32 GAAP operating income) | Exit | Fair value |
| --- | ---: | ---: |
| Fade alone, no outside view | $201 | $183 |
| 21.8x, the anchor's six peers' latest fiscal-year-end multiples, median | $291 | $237 |
| 22.3x, Oracle and SAP, the peers that grew like the exit | $296 | $240 |
| 24.2x, software company-years growing 5-10%, 2016-2025 | $315 | $251 |
| 29.7x, all eight peers' latest fiscal-year-end multiples, with Workday and ServiceNow | $370 | $284 |
| **30.9x, anchor (d) × what slowing companies fetched within their era** | **$381** | **$291** |
| 34.4x, anchor (d), the method's default | $415 | $312 |

The judgment range is **$237-312**. Below it sits only the fade alone. The
lower rows are defensible: the anchor's six peers ended their latest fiscal
years at a median 21.8x, and Salesforce itself at 23.7x (FY26). They are
single year-ends, which the method's ten-year window was built to smooth;
the 24.2x row rests on a cross-section of companies of all qualities, and
our Veeva work found cross-sections predict realised multiples worse than
the unmoved anchor. The call depends on this choice: every row at 24.2x or
below is a Hold.

**Cases.**

| Case | World | FY32 revenue | FY32 GAAP margin | Exit multiple | Exit | Fair value |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Bear | Labs own the interface and the agents; seats fall, prices stall, agents reach data directly | $46.6B | 17.3% | 21.5x | $102 | $107 |
| Central | Seats compress slowly in Service, price and premium editions offset, data grows 8% | $67.7B | 23.3% | 30.9x | $381 | $291 |
| Bull | Agents run through Salesforce; management's FY30 plan carried on | $81.0B | 28.3% | 45.7x | $826 | $572 |

Case-weighted (25/50/25, our weights) $316, above the central because the
bull is further away than the bear.

Cost of equity 10.14% = 5.29% risk-free + 1.155 beta × 4.20% premium (the
method's dated Damodaran pair, 2026-10-01). The beta is the Blume-adjusted
median of Adobe, Oracle, SAP, Intuit, Autodesk and Microsoft; Salesforce's
own 1.25 gives $283. Owner cash is paid out after after-tax interest at the
debt's 4.62% weighted coupon ($1.82B a year before tax), and the $39.5B of
debt and $0.6B of finance leases are deducted from the exit, held flat and
refinanced; cash is counted at face today, less the acquisitions already
paid and 3% of revenue for operations; strategic investments at carrying
value less tax on their gain. The exit is then an equity value, discounted
at the cost of equity like the payouts. Shares 797.8M: 823M on 2026-08-20 less our estimate of the
buyback's final delivery (26.2M, from the "≥14%" reduction management
expects) plus 1M dilutive awards.

**Sensitivity of the central** (`output.txt`, `review_answers.txt`): core
margin about ±$12 a point; data-group net retention 99% / 111% -$31 / +$26;
stock pay 8% / 10% +$13 / -$13; mature return at the central's own held
16.3% +$7, at 20% +$9; acquisitions at 6% of revenue -$11; growth after FY32
of 4% -$10, of 0% -$21; FY32 amortization of past acquisitions at $0 or the
whole $1,354M the 10-Q puts after FY31 +$6 / -$15 (we use $400M, our
assumption); a debt rate one point higher in the cost of capital -$1; each
$1B of revenue above our path held as a level +$7.0.

**Odds ranges, changed after the price was seen.** The odds tool refused
three driver ranges whose central sat too near their top (71-74% of the way
from bottom to top; it allows 29-71%). We kept every central and widened the
top only: Service seats to +3 points a year (from +2.5) and Sales seats to
+2.5 (from +2), both within the seat growth FY23-FY25 revenue implies after
list-price rises, and FY33 growth to 10% (from 9%), the bull's own value.
The acquisitions solve range now starts at 1.5% (from 0%), because below
about 1.2% of revenue the shared method cannot value the resulting harvest.
No value moved; the odds are run on the widened ranges. The model auditor
notes that the refused ranges cannot themselves be simulated, so there is no
valid before; the advocate capped the published draws at the old tops and P
moved from 54.0% to 53.7% (on the pre-review central). On the final model
the chance of a value at or below the bear ($107) is 3.9%, below the 5-25%
the odds tool expects of a one-in-five-to-ten case: our ranges may be too
narrow on the downside, which the advocate's combined world below also
suggests.

## 5. The market prices our forecast at a lower exit multiple

This section was written after the price, targets and estimates were read
(unblinded). Sections 1-4 and the model changed after it only through the
review answers in section 10.

At $247.55 our central case earns 14.2% a year to the exit, above the
10.14% cost of equity. The price equals our forecast at a 23.5x exit
multiple, between the 22.3x and 24.2x rows of the table in section 4: the
market pays for about our forecast at the multiple software companies
growing 5-10% fetched in 2016-2025, not the 30.9x we take from the peers'
anchor. The bear's multiple alone on our central forecast gives $235
(section 6), so the price is close to the de-rating path.

The Street's revenue path is ours to FY29: $46.3B, $50.9B and $55.7B for
FY27-FY29 against our $46.4B, $51.0B and $55.2B. It then runs ahead: $61.4B
in FY30 (16 analysts; ours $59.1B, 4% lower) and $71.5B in FY31 (17
analysts; ours $63.1B, 12% lower), close to management's $63B+ FY30 target
carried on. So the gap is not near-term growth; the Street is more
optimistic than we are on the later years and the market pays less than we
do for the exit. Its average 12-month target, $274.18, discounted a year at
our cost of equity is $248.94, about the price; our value is 1.17 times it.
The targets are falling: the one set in the last month is $250, against
$272.13 over the year. The Q3 FY27 print (expected 2026-12-02) settles part
of it: data-group organic growth above 10% supports the bull's retention,
below 5% the bear's.

**Alpha's view, 2026-10-26.** Alpha, the quantitative model, scores
Salesforce 86 of 100 (tier Strong), with expectations A, momentum B,
valuation B, growth C and quality D; it gives no rank today and flags its
data as limited, because goodwill and intangibles rose with acquisitions and
organic growth is unverified (`alpha ticker analyze CRM`). Its top drivers
are earnings surprises, the six-month price move and the free-cash-flow
yield; its top drag is the return on capital. We agree on the return on
capital: our fade gives acquired growth no value after FY32 for the same
reason. We differ on the surprises: Alpha reads them as momentum, we read a
company that guides close to its results (a median 0.51% beat) and whose
growth is increasingly bought.

**The chart, as timing only.** A technical quick read on 2026-10-26 grades
the chart B: an advancing trend after the 2026-08-27 results gap ($206 to
$252), above a rising 30-week average ($196) and the 50-day ($235), in a
range of $220-269 since; the October low ($220.29, 2026-10-08) held the
September low ($221.18), and the shares rose 43% over three months against
3% for QQQ. It is 1.6 average daily ranges above the 21-day average; the
range top, $264-269, is the resistance. Results are about 26 sessions away
(2026-12-02, not confirmed by the company). It falls to C on a close below
$220. The grade says when, never what Salesforce is worth, and it moved no
number here.

## 6. Why the other side could be right

**For a lower value.** The bear is a coherent world, not a stress test:
Claude, ChatGPT and Gemini become where work is done (Salesforce itself has
put its CRM inside Claude); customers buy agents from the labs and their
partners, priced per outcome; Service seats fall by a third; Salesforce
sells access to the record per call at prices it has not yet set (CFO,
2026-08-26); MuleSoft, Tableau and Informatica lose to agents that read data
directly; and the margin falls because the cost base was built for a seat
business. Each part has a dated sign today; none has shown in reported
revenue. Salesforce's record on acquisitions (a 5.8% median return on added
capital, below its cost of capital) also argues that the buying that props
up growth in our central destroys value; our fade already gives that growth
no value after FY32, but the five forecast years still pay for it.

**De-rating path.** If our central forecast holds but buyers in 2032 pay the
bear's 21.5x for it, as they might for a mature seat business under threat,
the stock is worth $235 today (`threat_bridge.txt`). What would keep the
multiple there: Service and Sales seat counts falling in Salesforce's own
disclosures, headless access staying unpriced, and data-group growth below
5%.

**For a higher value.** Seats are growing today and attrition is near a low;
premium-edition bookings more than doubled quarter on quarter (Q2 FY27); nine
of the ten largest AI companies run on Salesforce and Slack (Investor Day,
a management claim); management's FY30 plan implies about 11% growth. The
Anthropic stake ($5.1B carrying) could be marked well above that at a
listing. If the bull lands, the stock is worth $572.

## 7. Next results preview: Q3 FY27

Salesforce had not announced the date on 2026-10-26 (its investor-relations
event and news feeds); Q3 FY26 was released 2025-12-03. We expect early
December 2026.

| Metric | Our forecast | Range | Why |
| --- | ---: | --- | --- |
| Revenue ($B) | 11.52 | 11.42-11.62 | Guide midpoint plus the median beat |
| cRPO ($B) | 33.8 | 33.3-34.4 | +14% guided, a point beat as in Q2, plus Contentful and Fin, which the guide leaves out |
| Non-GAAP operating margin | 35.0% | 34.0-36.0% | 35.5% a year ago; acquisitions dilute H2 |
| FY27 revenue guidance midpoint ($B) | 46.40 | 46.25-46.60 | The Q3 beat carried through; Braze not until FY28 |
| Agentforce ARR ($B) | 1.85 | 1.70-2.10 | $1.2B to $1.5B last quarter on the widened scope |
| Attrition | about 8% | 7.5-9% | "Consistent" with the prior year |

Each $1B of annual revenue above our path, held, is worth about $7.0 a
share. The print that would move us: data-group growth without Informatica
(about 8% in H1) and any disclosed seat count or headless pricing.

## 8. Catalysts and falsifiers

- **Q3 FY27 results, early December 2026 (date not announced).** Data-group
  organic growth below 5% points to the bear's retention; above 10% to the
  bull's.
- **Headless and Claudeforce pricing.** A per-call or capacity price for
  agent access (the Max edition's promised Headless 360 allocation) is the
  first evidence of whether the record is paid for when the interface moves.
- **FY28 guidance, late February 2027.** Organic growth guided at 7.5% or
  less, or a non-GAAP margin below 34%, would lower the central's growth
  and margin drivers (each point of FY32 core margin is about $12 a share).
- **Braze close (FY28)** and any further acquisition above $5B.
- **Anthropic's listing.** A mark on Salesforce's stake.
- **Service seat disclosures.** Any statement that Service seats fell year
  on year.

## 9. Sources, dated

- Salesforce 10-K FY26, 10-Qs for Q1 and Q2 FY27, quarterly releases Q3 FY25
  to Q2 FY27, Investor Day deck (8-K 2026-09-16), Braze 8-K and investor
  webinar (2026-10-20), all SEC EDGAR, masked for price terms; saved in
  `data/`.
- Q1 and Q2 FY27 earnings call transcripts (market data/Quartr, captured
  2026-10-15; secondhand transcripts).
- Salesforce releases: Claudeforce (2026-08-26), new editions (2026-09-03),
  pricing updates (2023, 2025); IR event and news feeds read 2026-10-26
  (`data/web-captures.md`).
- Anthropic, PBC, Form S-1, 2026-10-26, pp. 10, 56, 182, 193, 237
  (`../2026-10-26-anthropic-s1/data/s1p.txt`).
- Gartner press releases 2025-03-05 and 2026-08-04 (summaries); Fortune
  2026-02-10, VentureBeat and Dealroom on the labs' enterprise moves (press);
  press reports of the CEO's support-headcount remarks (September 2025).
- Market data annual statements for Salesforce, its peers and Braze; fiscal-year-end
  EV/EBIT history (`data/exit-anchor.json`); the survivor-free exit-anchor
  study's software starts (`data/exit-outcomes-rows.json`).
- Damodaran implied equity risk premium and the 5.29% risk-free rate it is
  set against, 2026-10-01 (the method's dated pair).

This work was done with Claude, a model made by Anthropic, a company this
report assesses as a competitor and partner of Salesforce, and in which
Salesforce holds a stake: a conflict of interest.

## 10. What the two reviewers found, and our answers

Two outside reviewers read the committed draft with the market in hand: a
model auditor (Codex) and an opposite-side advocate (Opus), who argued for
Avoid. Every figure below is rerun by `review_answers.py`
(`review_answers.txt`) on the final model unless
marked. Net effect on the central: $287 to $291 (+$4.8): +$12.15 from the
debt basis, -$7.34 from Braze's margin. The call stays Buy.

| Reviewer | Finding | Answer | Effect on the central |
| --- | --- | --- | ---: |
| Auditor 1 | The 0.900 exit ratio rests on a sample without takeovers and failures that needs own history Salesforce lacks; 22.3x gives $234, 24.2x $246 | Disclosed. The limits are now stated beside the ratio, the table gains the six-peer latest row, and the text says every row at 24.2x or below is a Hold. The multiple is unchanged: the evidence for a lower one is the same history we judged blind, and no new dated fact separates the rows | 0 (rows at 22.3x and 24.2x now $240 and $251) |
| Auditor 2 | "Growth after FY32 adds no value" is wrong: the fade starts at a 65% return; FY33 growth of 0% costs $21.80 | Fixed (text). The fade's return falls from 65% to the cost of capital, so growth adds value until it gets there; growth of 0% reproduces at -$21.22 on the final model | 0 |
| Auditor 3 | The FY32 amortization of $400M has no filing support; $0 to $1,354M spans +$6.29 / -$14.98 | Disclosed as our assumption with both bounds, reproduced exactly; the 10-Q gives only "thereafter $1,354M" and the schedule falls each year (1,499, 1,189, 764, 497) | 0 |
| Auditor 4 | Enterprise cash flows discounted at the cost of equity with debt deducted today; at the WACC +$12.33; 5.55% is a coupon, not a market yield | Fixed. Payouts now bear after-tax interest at the 4.62% weighted coupon and debt is deducted at the exit, so both are equity flows at the cost of equity, the shared method's form. Reproduced +$12.15. The 5.55% is disclosed as the ten-year notes' issue coupon (March 2026), not a current yield; a point higher costs $1.15 | +12.15 |
| Auditor 5 | Post-price range changes need reconciliation; record.json says 30% confidence, the draws 26.1% | Fixed. The record now carries the counted confidence (28.5% on the final model; 26.1% reproduced on the draft); the range change and its P effect are reconciled in section 4 | 0 |
| Advocate 1 | Core margin: 34.1% in FY26 and Q2 FY27, 34.3% guided for FY27; 37.5% assumes expansion not yet shown; held at 34.3% the value is $249.5, a Hold. The flip | Rejected as an input change, disclosed. The figures were in our folder before the blind commit and no new dated fact is offered; holding the margin flat for five years while price per seat rises 20% would assume no operating leverage at all, against +3.6 points over FY24-FY26. Its worth: -$36.20 ($255, still above the price). This is the assumption that matters most, and the report's key driver | 0 (disclosed -36.20) |
| Advocate 2 | The 29.7x "peers' latest" row includes Workday and ServiceNow; the six anchor peers' latest median is 21.8x ($231); without Autodesk the anchor is 27.6x ($249) | Fixed (label and row): the row is relabelled and a 21.8x row added ($237 on the final model). Rejected for Autodesk: it has five valid years, the method's peer minimum, and the peer set was fixed before the fetch | 0 |
| Advocate 3 | Data-group organic growth fell from 10.2% (Q1) to 5.7% (Q2), a 103.7% retention run-rate: -$11.6 | Disclosed, not adopted: one quarter, which the CFO tied to license-revenue volatility; H1 organic growth (7.9%) is about our 106%. Reproduced -$10.90 on the final model | 0 (disclosed -10.90) |
| Advocate 4 | Braze at its own margin (non-GAAP about 8%, stock pay 15.7%): -$6.7 | Fixed, on Braze's Q2 FY27 release (2026-09-08, checked: non-GAAP operating income $22.0M on $227.2M of revenue; stock pay $35.7M; FY27 guide $75.5-76.5M on $910-913M). Margin path to 20% by FY32 is our assumption | -7.34 |
| Advocate 5 | Other acquired revenue at 15 points below the group margin: -$5.2 | Disclosed, not adopted: no dated source for the 15 points beyond Braze, which is now modelled on its own (reviewer's figure, not rerun) | 0 |
| Advocate 6 | Combined Avoid world (margin 34.3%, retention 103.7%, Braze at its margin, 24.2x): $199.5 | Disclosed as the strongest case for Avoid: $211.66 on the final model, about 15% below the price | 0 |

Flags the automatic checks raised on the final model, answered: flag 4
(low), the outside view 179% above the fade, is driven by the mature return
(section 4). Flag 23 (high): the odds' 90th percentile ($560) is 2% below
the bull ($572); the simulation reaches the bull in 9.4% of draws, so it can
reach our optimistic case, but our ranges are narrow at both ends (3.9% at
or below the bear). We tried widening the data-group retention and core
margin ranges both ways from history; the tails barely moved (90th $559),
because the exit-price draw and the worlds set them, so the ranges were
left as registered.

What held up, in the advocate's words: the seats and Agentforce treatment,
and the widened ranges (P 54.0% to 53.7%). The auditor confirmed all four
scripts, both generated JSON files, the odds and the 62 data pins reproduce
exactly, and that acquisition charges, Informatica, debt, stock pay, tax
and shares reconcile.

## Revision history

| Report | View | Pessimistic | Central | Optimistic | Central change | Price | Price read at (UTC) | Restated under | Blinding |
|---|---|---:|---:|---:|---:|---:|---|---|---|
| 2026-10-15-crm | hold | 122 | 239 | 331 | first | 246.70 | 2026-10-15T19:59:59Z | missing | partly unblinded |

- **2026-10-15, $239** (pessimistic $122, optimistic $331). First report:
  guidance, then 8.5% organic growth fading to 7%, valued at a judged 16.5x
  FY33 NOPAT set equal to its own fade. Never restated: its only
  reinvestment was working capital, which the shared method cannot fade.
- **2026-10-26, $291 (+$52).** Mostly a method change, then judgment, new
  data and two review fixes. How the $239 becomes $291:
  - *Method (shared rules).* The exit is now the mean of the long fade and
    an outside view (anchor (d) rules of 2026-10-16 and 2026-10-18, case
    spread of 2026-10-24) instead of a judged multiple equal to the fade.
    On this report's own forecast the fade alone gives $183, the old
    report's basis; adding the outside view at 30.9x gives $291. The
    outside view is the main source of the rise, about +$108 on our
    forecast. The mature-return rule H (2026-10-26) and its fix the same
    day (the cost-of-capital floor wins over a lower history cap) set the
    fade's return at 9.28% against the old 20%; inside the fade alone that
    lowers value.
  - *Judgment.* The forecast is rebuilt line by line with the AI threat as
    drivers. The central path ends close to the old one (FY32 revenue $67.7B
    against $68.3B), with a lower GAAP margin (23.8% after amortization
    against the old 27.7% before it) and acquisitions charged as
    reinvestment (3.5% of revenue a year, none in the old model). The old
    model's fade-based value was $239; this model's fade alone is $183. That
    $56 gap mixes the forecast, the acquisition charge and the fade's
    mature return (9.28% against 20%) and is not split here.
  - *Data.* Braze ($5.66B, FY28), Fin closed, Claudeforce and the new
    editions, the 9.0% stock-pay guide carried forward.
  - *Error fixed after review, made after the price was seen* (section 10):
    debt and interest put on the same equity basis as the payouts
    (+$12.15); Braze at its own margin from its 2026-09-08 release (-$7.34).
    The blind value was $277; the rule H fix took it to $287 before the
    market pass.
  - *Not separated:* the two models differ in structure (owner earnings
    before amortization against GAAP after it; payouts at year end against
    mid-year), so the steps above are an ordered reading, not a runnable
    bridge; the residual is not allocated.
  - *Exposure.* The table above, with the 2026-10-15 price, was read after
    this report's model was committed and pushed (commit 9b3cec05e); the old
    report's headings, read before, showed its $239 and that the price was
    then close to it. This revision is partly unblinded.